Trastuzumab in advanced breast cancer – a decade of experience in Germany

Overview of attention for article published in BMC Cancer, December 2014

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (70th percentile)
Good Attention Score compared to outputs of the same age and source (71st percentile)

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 34,623 followers.

Clinical benefit of treatment with #trastuzumab in elderly patients (>65 years) with advanced breast #cancer http://t.co/sTyOnhE4Si #breast

Clinical benefit of treatment with #trastuzumab in elderly patients (>65 years) with advanced breast #cancer http://t.co/sTyOnhE4Si #breast

Clinical benefit of treatment with #trastuzumab in elderly patients (>65 years) with advanced breast #cancer http://t.co/sTyOnhE4Si #breast

Clinical benefit of treatment with #trastuzumab in elderly patients (>65 years) with advanced breast #cancer http://t.co/sTyOnhE4Si #breast

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.